Home › Rheumatoid Arthritis › New Jersey
Rheumatoid Arthritis clinical trials in New Jersey
3 studies for Rheumatoid Arthritis are looking for participants at sites in New Jersey.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- Sahni Rheumatology & Therapy /ID# 278352, West Long Branch
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06972446A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Hackensack
- Nkarta Investigational Site, Summit
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.